ClouDr Group Past Earnings Performance
Past criteria checks 0/6
ClouDr Group has been growing earnings at an average annual rate of 35.2%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 31.1% per year.
Key information
35.2%
Earnings growth rate
54.5%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 31.1% |
| Return on equity | -16.6% |
| Net Margin | -7.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Slammed 29% ClouDr Group Limited (HKG:9955) Screens Well Here But There Might Be A Catch
Sep 02
Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper
Jun 09Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely
Apr 24ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward
Apr 17ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate
Feb 20An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued
Oct 07Revenue & Expenses Breakdown
How ClouDr Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,013 | -283 | 1,075 | 89 |
| 31 Mar 24 | 3,852 | -303 | 1,127 | 89 |
| 31 Dec 23 | 3,691 | -323 | 1,179 | 88 |
| 30 Sep 23 | 3,551 | -469 | 1,262 | 82 |
| 30 Jun 23 | 3,411 | -614 | 1,345 | 76 |
| 31 Mar 23 | 3,199 | -1,152 | 1,327 | 95 |
| 31 Dec 22 | 2,988 | -1,689 | 1,308 | 115 |
| 30 Sep 22 | 2,738 | -1,887 | 1,277 | 168 |
| 30 Jun 22 | 2,430 | -2,844 | 1,186 | 207 |
| 31 Mar 22 | 2,093 | -3,492 | 1,123 | 222 |
| 31 Dec 21 | 1,757 | -4,139 | 1,060 | 236 |
| 30 Sep 21 | 1,513 | -4,701 | 1,134 | 227 |
| 31 Dec 20 | 839 | -2,867 | 943 | 132 |
| 31 Dec 19 | 524 | -557 | 224 | 24 |
| 31 Dec 18 | 250 | -140 | 105 | 19 |
Quality Earnings: 9955 is currently unprofitable.
Growing Profit Margin: 9955 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9955 is unprofitable, but has reduced losses over the past 5 years at a rate of 35.2% per year.
Accelerating Growth: Unable to compare 9955's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9955 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).
Return on Equity
High ROE: 9955 has a negative Return on Equity (-16.62%), as it is currently unprofitable.